Physician profile
Jonathan Butler
NPI 1386753325
$620.21
in general payments reported to CMS, 2019-2025
14 companies · $285 in 2025
The $285 reported for 2025 was more than what a typical Addiction Medicine (Family Medicine) provider received nationally (typical 2025 total: $143).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36.01 · 2020: $58.46 · 2021: $18.59 · 2022: $16.25 · 2023: $206 · 2025: $285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $491.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $490.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $137.41 | 2025 | The Cologuard Plus Collection Kit |
| Novo Nordisk INC | $123.03 | 2025 | Wegovy |
| Axsome Therapeutics, INC. | $117.90 | 2023 | Auvelity |
| Pulmonx Corporation | $52.89 | 2023 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Alexion Pharmaceuticals, INC. | $29.98 | 2020 | |
| Daiichi Sankyo INC. | $24.18 | 2025 | Enhertu |
| Janssen Pharmaceuticals, INC | $21.64 | 2019 | |
| Abbvie INC. | $19.72 | 2023 | Vraylar |
| Indivior INC. | $18.59 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $17.16 | 2020 | |
| Idorsia Pharmaceuticals US INC | $16.25 | 2022 | |
| Alkermes, INC. | $15.77 | 2023 | Lybalvi |
| Sanofi Pasteur INC. | $14.37 | 2019 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $11.32 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Butler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.